New Gen4 Suit Offers Enhanced Design, Optimal Fit, and Superior Durability LAS VEGAS, Nov. 13, 2024 /PRNewswire/ -- Katalyst, the leader...
CHICAGO, IL / ACCESSWIRE / November 12, 2024 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified,...
GENEVA, SWITZERLAND / ACCESSWIRE / November 11, 2024 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY) (Relief, or the Company), a biopharmaceutical...
Trial reaches dosing milestone, with 20 of the 30 total patients dosedAll patients dosed met the primary endpoints of the...
NEW YORK, Nov. 4, 2024 /PRNewswire/ -- Biotia, a leading innovator in genomic-based infectious disease diagnostics, announced a major milestone...
AI-powered clinical intelligence prioritizes patient outreach based on likelihood of successful intervention to improve patient health and reduce costly emergency...
Additional ACG presentation to focus on impact of Xifaxan on OHE rehospitalizationsLAVAL, QC / ACCESSWIRE / October 27, 2024 /...
GENEVA, SWITZERLAND / ACCESSWIRE / October 21, 2024 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY ) (Relief, or the Company), a...
WINNIPEG, Manitoba, Oct. 17, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech” or “Kane”) announces that...
ATI-1701 provides full protection against lethal tularemia in animal models after one year Company to provide update on tularemia vaccine...
New Resin Eliminates >99.9% of Bacteria and Fungi In Vitro That Lead to Biofilm and Denture Stomatitis in 3D-Printed DenturesNEWPORT...
Dr. Diwan to Discuss "Shape-Shifting", "Trojan Horse", Pathogen-Directed Attack Capability of NanoViricides Platform Technology to Combat AMR SHELTON, CT /...
Program developed by Medavera, Inc. will take place during IDWeek 2024LOS ANGELES, CA / ACCESSWIRE / October 6, 2024 /...
WINNIPEG, Manitoba, Oct. 03, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech”, “Kane” or the “Company”)...
JERSEY CITY, N.J., Oct. 03, 2024 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to...
DSMC has reviewed the safety and pharmacokinetic data from Cohort 2 and recommended that the study proceed to enroll patients...
HACKENSACK, NJ/ ACCESSWIRE / October 1, 2024 / Royal Wound-X, a division of Royal Biologics, is proud to announce that...
An automated platform designed to fight against Sepsis and Antimicrobial Resistance (AMR) Enables rapid, automated microbial identification on the Bruker...
Visit Covalon at booth 523 to discover the latest in compassionate vascular access solutions MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the...
WINNIPEG, Manitoba, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech”, “Kane” or the “Company”)...